Alaeras

NCT02066428

A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS-404 Administered as Different Amounts of Antigen and Adjuvant Combinations in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection

NCT02074956

A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 Administered in Adults

NCT02430506

A Study to Evaluate Safety and Immunogenicity of AERAS-402 Administered in HIV-negative, BCG-vaccinated, QFT (+) and (-) Adults Without Evidence of TB

NCT02109874

A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 (C-011-404)

NCT02375256

A Leukapheresis Study for Immune Responses in Healthy US Adults Who Receive BCG Vaccination Followed by Boosting With AERAS-402

NCT01340820

Study of AERAS 422 in Healthy Adults

NCT02420444

A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive Adults

NCT01378312

A Study to Evaluate Safety and Immunogenicity of AERAS-402

NCT01967134

Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis

NCT01599897

Phase 1 ID93 + GLA-SE Vaccine Trial in Healthy Adult Volunteers

NCT01683773

Safety Study of Tuberculosis Vaccines AERAS-402 and MVA85A

NCT01927159

Phase 1 ID93 + GLA-SE Vaccine Trial in BCG-Vaccinated Healthy Adult Volunteers

NCT02063555

Phase I Trial of DAR-901

NCT02375698

A Phase I Study of Safety & Immunogenicity of AERAS-456 in HIV-Neg. Adults Treated for Drug-susceptible Pulmonary TB

NCT02378207

Safety and Immunogenicity Study of BCG, H4:IC31, and H56:IC31 Revaccination in Healthy Adolescents

NCT04674709

Evaluation of the Safety and Pharmacokinetics of Oleander 4X in Healthy Volunteers